NEO

NeoGenomics Inc.

Price

$17.17

return (12m)

75.74%

p/e

-42.90

p/bv

2.83

DIVIDEND YIELD

0.00%

NEO price

NeoGenomics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment NEO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.04%

3 months

5.47%

1 year

75.74%

2 years

26.34%

5 years

-62.97%

10 years

123.84%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NEO

Valuation

P/E

-42.90

Sector 0.64

Industry -1.62

P/BV

2.83

Sector 1.77

Industry 1.14

P/Revenue (PSR)

2.90

Sector 1.46

Industry 1.97

EV/EBITDA

181.96

Sector -46.22

Industry -35.08

EV/EBIT

-47.23

Sector -49.82

Industry -39.19

P/EBITDA

165.00

Sector -31.39

Industry -21.18

P/EBIT

-42.83

Sector -34.71

Industry -22.73

P/Total Assets

1.65

Sector 0.80

Industry 0.66

P/Net Current Assets

-12.03

Sector -24.72

Industry -64.12

P/Working Capital

8.08

Sector 2.45

Industry -2.19

EPS

-0.40

Sector -0.72

Industry -1.29

BVPS

6.06

Sector 4.27

Industry 2.63

Efficiency

Gross Margin

43.92%

Sector 49.00%

Industry 48.42%

EBITDA Margin

9.33%

Sector -236.77%

Industry -16,811,838.30%

EBIT Margin

-8.93%

Sector -20.23%

Industry -26.90%

Net Profit Margins

-6.77%

Sector -24.38%

Industry -28.94%

Asset Turnover

0.15

Sector 0.13

Industry 0.06

Profitability

ROE

-6.33%

Sector -27.00%

Industry -38.34%

ROA

-3.78%

Sector -25.58%

Industry -47.77%

ROIC

-3.54%

Sector -507.57%

Industry -794.26%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.60

Sector 1.92

Industry 2.55

Net Debt / EBITDA

16.95

Sector -21.38

Industry -8.23

Net Debt / EBIT

-4.40

Sector -6.87

Industry -36.54

Net Debt / Equity

0.29

Sector -0.58

Industry -1.17

Gross Debt / Equity

0.48

Sector -0.73

Industry -0.54

Equity/Assets

0.58

Sector 0.45

Industry 0.52

Liabilities/Assets

0.42

Sector 0.49

Industry 0.46

Growth

5Y Revenue CAGR

9.61%

Sector -

Industry -

5Y Earnings CAGR

44.11%

Sector -

Industry -

Fundamentals NEO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NEO NeoGenomics Inc.	$17.17	67.02%	0.00%	-42.90	2.83	-6.33%	-6.77%
CI Cigna Corp.	$298.72	2.12%	2.07%	11.53	1.85	16.51%	2.42%
UHS Universal Health Services Inc.	$177.06	-21.07%	0.45%	6.92	1.39	20.81%	8.42%
DGX Quest Diagnostics Inc.	$251.57	46.36%	1.40%	25.29	3.43	13.58%	9.19%
STRRP Star Equity Holdings Inc.	$8.95	-1.55%	10.10%	7.62	2.39	31.31%	25.96%
ENSG The Ensign Group, Inc	$185.00	1.44%	0.14%	28.31	4.38	16.96%	6.90%
CRVL CorVel Corporation	$82.04	11.70%	0.00%	36.14	10.19	30.70%	11.72%
OPCH Option Care Health Inc.	$31.88	11.20%	0.00%	23.26	3.87	16.00%	3.68%
JYNT The Joint Corp.	$7.02	-13.76%	0.00%	26.33	6.30	19.41%	6.49%
PGNY Progyny Inc.	$28.62	49.92%	0.00%	28.80	5.00	17.35%	6.00%
PNTG The Pennant Group Inc.	$42.20	68.60%	0.00%	45.49	3.63	8.76%	2.93%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NEO - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.23%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/16/2020	12/30/2020	0.40000000

ABOUT NeoGenomics

NeoGenomics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

28 years

Founded: 1998

1996

Time since IPO - 30 years

1.700

Employees

NeoGenomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.23 billion, with shareholders equity totaling $785.73 million.

The company employs approximately 1.700 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, NeoGenomics Inc. reported $766.30 million in revenue, generating net income of $-51.88 million.

Key financial metrics include a P/E ratio of -42.90, a price-to-book (P/B) ratio of 2.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEO.

Market cap

$2.23 billion

Net worth

$785.73 million

$785,732,000.00

Assets

$1.35 billion

$1,352,243,000.00

Total Shares Outstanding

129.63 million

129,628,000

Average Daily Trading Volume

$2.09 million

$2,090,066.00

Sector

Health

Industry

Health Establishments

NEO

NEO revenue and profits

Financial Results NEO

DRAG THE FRAME TO SEE MORE DATA

NEO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$90.62 19,62% (12M)

P/E

23.70

3.67%

ROE

6.21%

P/BV

1.45

CI - Cigna

$298.72 24,98% (12M)

P/E

11.53

2.07%

ROE

16.51%

P/BV

1.85

CNC - Centene

$67.08 89,65% (12M)

P/E

-6.50

0.00%

ROE

-20.35%

P/BV

1.46

HUM - Humana

$412.17 49,80% (12M)

P/E

38.69

0.65%

ROE

6.81%

P/BV

2.57

SNY - Sanofi

$44.62 --8,31% (12M)

P/E

4.18

3.96%

ROE

18.43%

P/BV

0.77

JNJ - Johnson & Johnson

$275.85 49,36% (12M)

P/E

41.75

1.92%

ROE

20.02%

P/BV

8.24

LLY - Eli Lilly

$1,421.92 65,83% (12M)

P/E

46.06

0.47%

ROE

86.09%

P/BV

31.54

HCA - HCA Healthcare

$479.56 5,05% (12M)

P/E

15.46

0.64%

ROE

-307.62%

P/BV

-32.96